Loading clinical trials...
Loading clinical trials...
Pain Self-Management Intervention to Reduce Pain & Improve MOUD Engagement in Primary Care: A Randomized Trial
The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participants engage in treatment for opioid use? Researchers will compare PSM to standard care to see if PSM is effective in managing chronic pain and engagement in treatment. Participants will: * Take part in the PSM program or receive standard care for 12 weeks after enrolling in the study * Complete surveys every 3 months for 9 months (total of 4 visits) Participants will receive compensation for participating in the study. There are risks associated with participating in the study, including breach of confidentiality and psychological distress caused by discussing difficult topics.
This is randomized trial of a pain self-management (PSM) intervention for chronic pain tailored to individuals with opioid misuse or opioid use disorder (OUD) as compared to usual care. The investigators hypothesize that PSM will be effective in improving both reducing pain and improving MOUD engagement among individuals with co-occurring opioid misuse/OUD and chronic pain. This is a multisite trial recruiting from primary care clinics located in Pennsylvania, West Virginia and Maryland. Interventions: Participants will be randomized to either PSM or Usual Care. Pain Self-Management (PSM): PSM is a manualized pain self-management behavioral intervention tailored to patients with chronic pain and opioid misuse/OUD. PSM consists of 10 intervention sessions delivered via phone or web-based communication platform. Sessions will be led by a staff interventionist. Usual Care (UC): Usual care or "treatment as usual" refers to the standard of care that patient participants receive at their primary care clinic. The standard of care for patients is to discuss issues related to chronic pain and opioid use with their providers and to receive clinical care for these conditions. Study Duration: \~27 months (18 months of recruitment + 9 months follow-up) Participant Duration: 9 months
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Renaissance Family Practice - Hampton Office
Allison Park, Pennsylvania, United States
Renaissance Family Practice - RIDC Office
Blawnox, Pennsylvania, United States
Renaissance Family Practice - Glenshaw Office
Glenshaw, Pennsylvania, United States
Renaissance Family Practice - Millvale Office
Pittsburgh, Pennsylvania, United States
Community Medicine, Inc.
Pittsburgh, Pennsylvania, United States
UPMC General Internal Medicine-Montefiore
Pittsburgh, Pennsylvania, United States
Renaissance Family Practice - Aspinwall Office
Pittsburgh, Pennsylvania, United States
UPMC General Internal Medicine-Shadyside (Shea Medical Center)
Pittsburgh, Pennsylvania, United States
Renaissance Family Practice - Harmarville Office
Pittsburgh, Pennsylvania, United States
UPMC General Internal Medicine-Turtle Creek
Turtle Creek, Pennsylvania, United States
Start Date
November 25, 2024
Primary Completion Date
July 31, 2026
Completion Date
December 31, 2026
Last Updated
October 3, 2025
204
ESTIMATED participants
Usual Care
BEHAVIORAL
Pain Self-Management
BEHAVIORAL
Lead Sponsor
University of Pittsburgh
Collaborators
NCT06651177
NCT04379115
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06587607